glp-1 drugs heart failure keep getting more interesting… This new study suggests they may directly slow atherosclerosis and inflammation — even without weight loss or diabetes. ⚠️ But remember: animal data ≠ human outcomes GLP-1 Agonist Therapy for Advanced

Researchers can then compare what was seen during the active period with what happens afterward

This design choice introduces potential bias, particularly for subjective outcomes, but it reflects the practical reality that these treatments have different injection devices and titration schedules that would make blinding extremely difficult

injection-video Clean the injection site, insert the needle at a 4590-degree angle, and inject the medication slowly

Most patients report little to no discomfort

Yes, spotting between periods needs medical attention

Sermorelin remains used in some dynamic GH stimulation tests in pediatric endocrinology, but this is a historical clinical use rather than a reference in preclinical research